Fatty Acid Synthase: An Emerging Target in Cancer
- PMID: 32872164
- PMCID: PMC7504791
- DOI: 10.3390/molecules25173935
Fatty Acid Synthase: An Emerging Target in Cancer
Abstract
In recent years, lipid metabolism has garnered significant attention as it provides the necessary building blocks required to sustain tumor growth and serves as an alternative fuel source for ATP generation. Fatty acid synthase (FASN) functions as a central regulator of lipid metabolism and plays a critical role in the growth and survival of tumors with lipogenic phenotypes. Accumulating evidence has shown that it is capable of rewiring tumor cells for greater energy flexibility to attain their high energy requirements. This multi-enzyme protein is capable of modulating the function of subcellular organelles for optimal function under different conditions. Apart from lipid metabolism, FASN has functional roles in other cellular processes such as glycolysis and amino acid metabolism. These pivotal roles of FASN in lipid metabolism make it an attractive target in the clinic with several new inhibitors currently being tested in early clinical trials. This article aims to present the current evidence on the emergence of FASN as a target in human malignancies.
Keywords: cancer; fatty acid synthase; lipid metabolism.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Ventura R., Mordec K., Waszczuk J., Wang Z., Lai J., Fridlib M., Buckley D., Kemble G., Heuer T.S. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression. EBioMedicine. 2015;2:808–824. doi: 10.1016/j.ebiom.2015.06.020. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
